Results 241 to 250 of about 70,369 (254)

Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas

Cancer Letters, 2015
Alfeu Zanotto-Filho, Elizandra Braganhol, Fabricio Figueiro   +2 more
exaly  

Crystal Engineering of Stable Temozolomide Cocrystals

Chemistry - an Asian Journal, 2012
N Jagadeesh Babu, Palash Sanphui
exaly  

Temozolomide for immunomodulation in the treatment of glioblastoma

Neuro-Oncology, 2018
Aida Karachi, Farhad Dastmalchi, Duane A Mitchell   +2 more
exaly  

Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas

Expert Review of Neurotherapeutics, 2010
Marc C Chamberlain
exaly  

Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG)

Annals of Oncology, 2006
M E Trudeau, M Crump, D Charpentier
exaly  

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF

Annals of Oncology, 2014
L Taillandier, D Frappaz, H Taillia
exaly  

Temozolomide in the treatment of solid tumours: current results and rationale for dosing/scheduling

Critical Reviews in Oncology/Hematology, 2005
M R Middleton
exaly  

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study

Neuro-Oncology, 2016
Regina I Jakacki, Kenneth J Cohen, Allen Buxton   +2 more
exaly  

Temozolomide

Reactions Weekly, 2006
openaire   +1 more source

Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells

Journal of Neuro-Oncology, 2015
Ryuta Saito, Ichiyo Shibahara, Masayuki Kanamori   +2 more
exaly